Literature DB >> 23961504

Cornelia de Lange syndrome.

H Babul Reddy1, K Neelaveni, K V S Hari Kumar.   

Abstract

Entities:  

Year:  2013        PMID: 23961504      PMCID: PMC3743388          DOI: 10.4103/2230-8210.113779

Source DB:  PubMed          Journal:  Indian J Endocrinol Metab        ISSN: 2230-9500


× No keyword cloud information.
Sir, A 9-year-old girl was brought by parents for evaluation of short stature. The girl is a product of non-consanguineous marriage and was delivered pre-term by cesarean section with birth weight of 1.5 kg. The parents noticed delays in milestones during development. Her scholastic performance was below average and parents denied any features to suggest neurological disease. Parents denied birth trauma or similar illness in other family members. Examination revealed severe short stature (112 cm, <3rd centile), height SDS, (Standard Deviation Score) 3.5; upper/lower segment ratio, 0.9; head circumference, 46 cm; and underweight (19 kg, <3rd centile). She had low anterior hair line, synophrys (bushy eyebrows meeting in mid-line), arched eye brows, low set ears, and maxillary hypoplasia [Figure 1a]. Other examination revealed small hands, clinodactyly [Figure 1b], single palmar crease, and hypertrichosis [Figure 1c]. She was pre-pubertal with B1P1 on Tanner staging and rest of the systemic examination was normal. She was clinically diagnosed as a case of Cornelia de Lange syndrome (CDLS). Her investigations revealed normal hematological and biochemical parameters with bone age of 8 years. Thyroid panel was diagnostic of subclinical hypothyroidism (Thyroid Stimulating Hormone TSH: 8.4 mIU/mL with normal T3 and T4). She was evaluated for growth hormone deficiency after adequate thyroxine replacement. Peak Growth hormone GH < after stimulation was 2.4 ng/mL and she was started on GH replacement therapy. Her echocardiography was normal and karyotyping revealed 46XX. Intelligence Quotient testing revealed score of 70 equivalent to a 5-year-old child. She continued to receive GH and Thyroxine therapy along with psychosocial rehabilitation program. During last review, she gained 10 cm in 1st year of GH therapy.
Figure 1

Clinical photograph

Clinical photograph CDLS is a relatively uncommon genetic disorder characterized by growth retardation, developmental delay, hirsutism, mental retardation, and structural abnormalities.[1] The vast majority of cases are due to spontaneous mutations involving genes like NIPBL on chromosome 5, SMC1A on X chromosome, and SMC3 on chromosome 10.[2] The diagnosis of CDLS is clinical based on signs and symptoms. Two phenotypes are described with type 1 is the classical variety and type 2 being the mild variant. Short stature in CDLS is due to GH deficiency and resistance.[3] The patients show good response to GH therapy in former. The life expectancy is limited to few years only and the common cause of death is pneumonia along with cardio-respiratory structural abnormalities.
  3 in total

1.  Physical growth in Brachmann-de Lange syndrome.

Authors:  B G Kousseff; J Thomson-Meares; P Newkirk; A W Root
Journal:  Am J Med Genet       Date:  1993-11-15

2.  Aesthetic and functional management of a patient with Cornelia de Lange syndrome.

Authors:  Dexton Antony Johns; Dnyanesh L Bhonsale; V Y Shivashanker; Manu Johns
Journal:  Contemp Clin Dent       Date:  2012-04

Review 3.  Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance.

Authors:  Antonie D Kline; Ian D Krantz; Annemarie Sommer; Mark Kliewer; Laird G Jackson; David R FitzPatrick; Alex V Levin; Angelo Selicorni
Journal:  Am J Med Genet A       Date:  2007-06-15       Impact factor: 2.802

  3 in total
  1 in total

1.  Cornelia de Lange syndrome in diverse populations.

Authors:  Leah Dowsett; Antonio R Porras; Paul Kruszka; Brandon Davis; Tommy Hu; Engela Honey; Eben Badoe; Meow-Keong Thong; Eyby Leon; Katta M Girisha; Anju Shukla; Shalini S Nayak; Vorasuk Shotelersuk; Andre Megarbane; Shubha Phadke; Nirmala D Sirisena; Vajira H W Dissanayake; Carlos R Ferreira; Monisha S Kisling; Pranoot Tanpaiboon; Annette Uwineza; Leon Mutesa; Cedrik Tekendo-Ngongang; Ambroise Wonkam; Karen Fieggen; Leticia Cassimiro Batista; Danilo Moretti-Ferreira; Roger E Stevenson; Eloise J Prijoles; David Everman; Kate Clarkson; Jessica Worthington; Virginia Kimonis; Fuki Hisama; Carol Crowe; Paul Wong; Kisha Johnson; Robin D Clark; Lynne Bird; Diane Masser-Frye; Marie McDonald; Patrick Willems; Elizabeth Roeder; Sulgana Saitta; Kwame Anyane-Yeoba; Laurie Demmer; Naoki Hamajima; Zornitza Stark; Greta Gillies; Louanne Hudgins; Usha Dave; Stavit Shalev; Victoria Siu; Ann Ades; Holly Dubbs; Sarah Raible; Maninder Kaur; Emanuela Salzano; Laird Jackson; Matthew Deardorff; Antonie Kline; Marshall Summar; Maximilian Muenke; Marius George Linguraru; Ian D Krantz
Journal:  Am J Med Genet A       Date:  2019-01-06       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.